Literature DB >> 17823922

Genome-wide linkage scan, fine mapping, and haplotype analysis in a large, inbred, Arab Israeli pedigree suggest a schizophrenia susceptibility locus on chromosome 20p13.

Omri Teltsh1, Kyra Kanyas, Osnat Karni, Adi Levi, Mira Korner, Edna Ben-Asher, Doron Lancet, Adnan Hamdan, Bernard Lerer, Yoav Kohn.   

Abstract

Linkage and association studies in schizophrenia have repeatedly drawn attention to several chromosomal regions and to genes within them. Conflicting patterns of association and the lack of a clear functional significance of the associated variants limit the interpretation of these results. The use of rare pedigrees, where genes with a major effect cause the disorder, has been proven beneficial in studies of other complex disorders. Our objective was to use this advantage by performing a genome wide linkage analysis for schizophrenia in a large, multiplex Israeli Arab pedigree. We genotyped 346 microsatellite markers in 24 pedigree members affected with schizophrenia spectrum disorders and 32 unaffected relatives. Two-point linkage analysis with SUPERLINK demonstrated a LOD score of 2.47 for D20S116 on chromosome 20p13 under an autosomal dominant mode of inheritance. Further fine mapping yielded a two-point LOD score of 2.56 for the adjacent marker D20S193 and narrowed down the linked region to 2-5 cM. A haplotype containing the markers D20S193, D20S889, and D20S116, 0.7 Mb in length, was found to be shared by most affected pedigree members. Genotyping of 43 SNPs in the interval supported these results with a multipoint LOD score of 2.7 around D20S193. We were also able to better define the boundaries of the shared haplotype which contains strong candidate genes for schizophrenia. Our study exemplifies the power of rare and unique pedigrees in drawing attention to novel regions for genetic studies of schizophrenia. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17823922     DOI: 10.1002/ajmg.b.30591

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  9 in total

1.  Resequencing and association analysis of PTPRA, a possible susceptibility gene for schizophrenia and autism spectrum disorders.

Authors:  Jingrui Xing; Chenyao Wang; Hiroki Kimura; Yuto Takasaki; Shohko Kunimoto; Akira Yoshimi; Yukako Nakamura; Takayoshi Koide; Masahiro Banno; Itaru Kushima; Yota Uno; Takashi Okada; Branko Aleksic; Masashi Ikeda; Nakao Iwata; Norio Ozaki
Journal:  PLoS One       Date:  2014-11-13       Impact factor: 3.240

2.  Loss of function studies in mice and genetic association link receptor protein tyrosine phosphatase α to schizophrenia.

Authors:  Nagahide Takahashi; Karin Sandager Nielsen; Branko Aleksic; Steffen Petersen; Masashi Ikeda; Itaru Kushima; Nathalie Vacaresse; Hiroshi Ujike; Nakao Iwata; Véronique Dubreuil; Naheed Mirza; Takeshi Sakurai; Norio Ozaki; Joseph D Buxbaum; Jan Sap
Journal:  Biol Psychiatry       Date:  2011-08-10       Impact factor: 13.382

Review 3.  Co-shared genetics and possible risk gene pathway partially explain the comorbidity of schizophrenia, major depressive disorder, type 2 diabetes, and metabolic syndrome.

Authors:  Teodor T Postolache; Laura Del Bosque-Plata; Serge Jabbour; Michael Vergare; Rongling Wu; Claudia Gragnoli
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2019-02-06       Impact factor: 3.568

4.  Potential translational targets revealed by linking mouse grooming behavioral phenotypes to gene expression using public databases.

Authors:  Andrew Roth; Evan J Kyzar; Jonathan Cachat; Adam Michael Stewart; Jeremy Green; Siddharth Gaikwad; Timothy P O'Leary; Boris Tabakoff; Richard E Brown; Allan V Kalueff
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-10-31       Impact factor: 5.067

5.  Rare variants in Protein tyrosine phosphatase, receptor type A (PTPRA) in schizophrenia: Evidence from a family based study.

Authors:  Jibin John; Prachi Kukshal; Aditya Sharma; Triptish Bhatia; V L Nimgaonkar; S N Deshpande; B K Thelma
Journal:  Schizophr Res       Date:  2018-12-27       Impact factor: 4.939

6.  Correspondence of DNA Methylation Between Blood and Brain Tissue and Its Application to Schizophrenia Research.

Authors:  Esther Walton; Johanna Hass; Jingyu Liu; Joshua L Roffman; Fabio Bernardoni; Veit Roessner; Matthias Kirsch; Gabriele Schackert; Vince Calhoun; Stefan Ehrlich
Journal:  Schizophr Bull       Date:  2015-06-08       Impact factor: 9.306

7.  Comparative linkage meta-analysis reveals regionally-distinct, disparate genetic architectures: application to bipolar disorder and schizophrenia.

Authors:  Brady Tang; Tricia Thornton-Wells; Kathleen D Askland
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  High frequency of known copy number abnormalities and maternal duplication 15q11-q13 in patients with combined schizophrenia and epilepsy.

Authors:  Larissa R Stewart; April L Hall; Sung-Hae L Kang; Chad A Shaw; Arthur L Beaudet
Journal:  BMC Med Genet       Date:  2011-11-25       Impact factor: 2.103

9.  Comprehensive gene-based association study of a chromosome 20 linked region implicates novel risk loci for depressive symptoms in psychotic illness.

Authors:  T Bernard Bigdeli; Brion S Maher; Zhongming Zhao; Edwin J C G van den Oord; Dawn L Thiselton; Jingchun Sun; Bradley T Webb; Richard L Amdur; Brandon Wormley; Francis A O'Neill; Dermot Walsh; Brien P Riley; Kenneth S Kendler; Ayman H Fanous
Journal:  PLoS One       Date:  2011-12-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.